127 related articles for article (PubMed ID: 7063110)
1. Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses.
Heal DJ; Atterwill CK
Neuropharmacology; 1982 Feb; 21(2):159-62. PubMed ID: 7063110
[TBL] [Abstract][Full Text] [Related]
2. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
3. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
Ford AP; Marsden CA
Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
[TBL] [Abstract][Full Text] [Related]
4. High-speed chronoamperometric measurements of mesolimbic and nigrostriatal dopamine release associated with repeated daily stress.
Doherty MD; Gratton A
Brain Res; 1992 Jul; 586(2):295-302. PubMed ID: 1325860
[TBL] [Abstract][Full Text] [Related]
5. Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat.
Oakley NR; Hayes AG; Sheehan MJ
Psychopharmacology (Berl); 1991; 105(2):204-8. PubMed ID: 1686655
[TBL] [Abstract][Full Text] [Related]
6. Lesions of the superior colliculus in the rat differentiate between nigrostriatal and mesolimbic dopamine systems.
Dawbarn D; Pycock CJ
Brain Res; 1982 Mar; 235(1):148-55. PubMed ID: 6892367
[TBL] [Abstract][Full Text] [Related]
7. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
8. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways.
Richardson SA; Tizabi Y
Pharmacol Biochem Behav; 1994 Feb; 47(2):331-7. PubMed ID: 8146225
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
10. Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
de Bruin NM; van Luijtelaar EL; Jansen SJ; Cools AR; Ellenbroek BA
Neurosci Res; 2000 Oct; 38(2):165-73. PubMed ID: 11000443
[TBL] [Abstract][Full Text] [Related]
11. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus.
Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C
Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315
[TBL] [Abstract][Full Text] [Related]
12. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
13. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
Jackson EA; Neumeyer JL; Kelly PH
Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
[TBL] [Abstract][Full Text] [Related]
14. Nigral dopaminergic mechanisms in drug-induced circling.
Jackson EA; Kelly PH
Brain Res Bull; 1983 Nov; 11(5):605-11. PubMed ID: 6607768
[TBL] [Abstract][Full Text] [Related]
15. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
Bardo MT; Bowling SL; Pierce RC
Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
[TBL] [Abstract][Full Text] [Related]
16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
18. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
[TBL] [Abstract][Full Text] [Related]
19. The rotating rodent: a two component system?
Pycock CJ; Marsden CD
Eur J Pharmacol; 1978 Jan; 47(2):167-75. PubMed ID: 340238
[TBL] [Abstract][Full Text] [Related]
20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
